Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.9M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
30.6K
-
Shares change
-
+6.62K
-
Total reported value, excl. options
-
$661K
-
Value change
-
+$143K
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$21.58
Significant Holders of CASTLE BIOSCIENCES INC - Common Stock (CSTL) as of Q4 2023
2 filings reported holding CSTL - CASTLE BIOSCIENCES INC - Common Stock as of Q4 2023.
CASTLE BIOSCIENCES INC - Common Stock (CSTL) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.6K shares
of 28.9M outstanding shares and own 0.11% of the company stock.
Largest 10 shareholders include WASATCH ADVISORS LP (2.59M shares), BlackRock Inc. (2.28M shares), Granahan Investment Management, LLC (2.17M shares), PRINCIPAL FINANCIAL GROUP INC (1.59M shares), VANGUARD GROUP INC (1.46M shares), Bellevue Group AG (1.23M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (965K shares), Portolan Capital Management, LLC (729K shares), MILLENNIUM MANAGEMENT LLC (716K shares), and DIMENSIONAL FUND ADVISORS LP (664K shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.